Jefferies Financial Group Inc. acquired a new position in shares of ICU Medical, Inc. (NASDAQ:ICUI – Free Report) during the 3rd quarter, HoldingsChannel.com reports. The institutional investor acquired 6,152 shares of the medical instruments supplier’s stock, valued at approximately $987,000.
Other large investors also recently added to or reduced their stakes in the company. Allworth Financial LP purchased a new stake in shares of ICU Medical in the second quarter valued at $26,000. Versant Capital Management Inc boosted its position in shares of ICU Medical by 26.2% in the third quarter. Versant Capital Management Inc now owns 313 shares of the medical instruments supplier’s stock worth $50,000 after buying an additional 65 shares during the period. Public Employees Retirement System of Ohio purchased a new position in shares of ICU Medical during the second quarter valued at $51,000. Nykredit A S purchased a new position in shares of ICU Medical during the second quarter valued at $135,000. Finally, Vise Technologies Inc. purchased a new position in shares of ICU Medical during the third quarter valued at $227,000. 96.10% of the stock is owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other ICU Medical news, VP Virginia Sanzone sold 4,856 shares of the business’s stock in a transaction dated Thursday, September 3rd. The stock was sold at an average price of $168.69, for a total value of $819,158.64. Following the transaction, the vice president owned 14,604 shares in the company, valued at $2,463,548.76. The trade was a 24.95% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Elisha W. Finney sold 1,700 shares of the company’s stock in a transaction dated Friday, November 13th. The stock was sold at an average price of $179.00, for a total value of $304,300.00. Following the completion of the transaction, the director directly owned 4,871 shares in the company, valued at approximately $871,909. The trade was a 25.87% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 6,621 shares of company stock valued at $1,135,094. Insiders own 2.10% of the company’s stock.
Analyst Upgrades and Downgrades
ICUI has been the topic of several recent analyst reports. Piper Sandler upped their price target on ICU Medical from $195.00 to $200.00 and gave the company an “overweight” rating in a research report on Friday, November 6th. BTIG Research raised their price objective on ICU Medical from $170.00 to $200.00 and gave the stock a “buy” rating in a research report on Friday, August 7th. Needham & Company LLC lifted their target price on ICU Medical from $165.00 to $187.00 and gave the company a “buy” rating in a research note on Friday, August 7th. KeyCorp lifted their target price on ICU Medical from $187.00 to $189.00 and gave the company an “overweight” rating in a research note on Friday, November 6th. Finally, Zacks Research downgraded ICU Medical from a “strong-buy” rating to a “hold” rating in a report on Tuesday, July 28th. Two analysts have rated the stock with a Strong Buy rating, four have given a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, ICU Medical presently has an average rating of “Moderate Buy” and an average target price of $195.20.
View Our Latest Research Report on ICU Medical
ICU Medical Stock Up 1.1%
ICUI stock traded up $1.97 during midday trading on Friday, reaching $179.27. The company had a trading volume of 195,454 shares, compared to its average volume of 278,884. ICU Medical, Inc. has a 1 year low of $113.37 and a 1 year high of $192.85. The company has a current ratio of 2.37, a quick ratio of 1.19 and a debt-to-equity ratio of 0.52. The company has a market capitalization of $4.48 billion, a P/E ratio of 75.01, a PEG ratio of 2.23 and a beta of 0.88. The company has a 50 day moving average of $163.72 and a two-hundred day moving average of $149.91.
ICU Medical (NASDAQ:ICUI – Get Free Report) last posted its quarterly earnings results on Thursday, November 5th. The medical instruments supplier reported $2.44 EPS for the quarter, beating the consensus estimate of $2.14 by $0.30. ICU Medical had a net margin of 2.76% and a return on equity of 8.40%. The business had revenue of $556.22 million for the quarter, compared to analysts’ expectations of $552.03 million. During the same period in the previous year, the company posted $2.03 EPS. ICU Medical’s revenue was up 4.4% on a year-over-year basis. On average, equities research analysts expect that ICU Medical, Inc. will post 7.22 earnings per share for the current fiscal year.
ICU Medical Company Profile
ICU Medical is a medical technology company that develops, manufactures and markets products used in infusion therapy, vascular access and critical care. Its offerings include infusion pumps and related sets and accessories, IV solutions, needlefree connectors, and products designed to help protect healthcare workers when handling hazardous drugs. Founded in 1984, the company expanded its product portfolio through acquisitions, including the infusion systems business of Hospira in 2017 and Smiths Medical in 2022.
See Also
- Five stocks we like better than ICU Medical
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
- Is It Too Late to Buy the Dip? 3 Corners of the Market Still Offering Real Value
Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Inc. (NASDAQ:ICUI – Free Report).
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.
